Cronos Group Stock Price to Suffer an Earnings Restatement Penalty

Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…

Read More

Why Is Cronos Group (TSX:CRON) Delaying Its Earnings Results?

Cannabis producer and innovation giant Cronos Group (TSX:CRON)(NASDAQ:CRON) announced on Monday that it will delay the release of its fourth quarter and full year 2019 earnings results originally slated for Thursday, February 27 as it has experienced a delay. No reason was given for the earnings release postponement, no new specific date was given for the delayed filings and the…

Read More

This Small-Cap Pot Stock Beats Canopy to Profitability

When you think about marijuana stocks, you probably think about big names like Canopy Growth and Aurora Cannabis. These companies aren’t turning a profit yet and won’t be profitable any time soon. The first full year of cannabis legalization in Canada has been challenged by scandals, oversupply problems, and lack of visibility in retail. The factors all put downward pressure…

Read More

Should You Buy Organigram (TSX:OGI) Stock Today?

The fact that cannabis producer Organigram Holdings (TSX:OGI)(NASDAQ:OGI) delivered a 102% year-over-year net revenue growth for the recently reported first quarter of fiscal 2020 doesn’t move me as much as a 54% sequential sales increase over a recent previous quarter does. The year-over-year comparison pits one quarter with very little recreational pot sales generated in just one full month and…

Read More

$100 Billion Tobacco Giant Altria (NYSE:MO) Just Bet Big on This Cannabis Stock

The cannabis industry has been hit hard in recent months, with popular marijuana-based ETFs down 50% or more. Yet recent actions from $100 billion tobacco behemoth Altria Group (NYSE:MO) could signal a bottom. On November 20, Altria purchased four million shares of Cronos Group (TSX:CRON)(NASDAQ:CRON), adding to its existing position in the company. Notably, the purchases follow a steep 70%…

Read More

Will Cronos (TSX:CRON) Stock Move Higher After a 25% Decline Last Week?

Shares of leading cannabis company Cronos Group (TSX:CRON)(NASDAQ:CRON) fell over 25% in the last week. Why did Cronos Group investors lose a quarter of their market value in the week ended on November 15, 2019? Cronos Group announced its third-quarter results on November 12 and reported sales of $12.7 million — 238% higher compared to sales of $3.76 million in…

Read More

Akerna Corp. (NASDAQ: KERN) Surges 56% After Reporting Fiscal First Quarter 2020 Financial Results

Akerna Corp. (NASDAQ: KERN) is engaged as a cannabis technology company, which aims to help cannabis startups navigate the complexities of compliance and maintaining regulatory good-standing. The company’s system helps track regulated cannabis products from seed-to-store. Akerna has tracked over $16 billion in cannabis sales since its launch. Shares of the cannabis technology company surged 56.30%, through trading on Friday,…

Read More

Cannabis Investors: 3 Big Changes Coming Soon to Cronos Group’s (TSX:CRON)

Cannabis firm Cronos Group (TSX:CRON)(NASDAQ:CRON) reported its third-quarter financial results on Wednesday this week and management has announced some significant changes to the business. Investors need be aware of the following fundamental changes to the company’s future operations and financial results presentations going forward. Here’s what you need to know. Big change in applicable accounting standards First, the company will…

Read More

Better Cannabis Buy: Cronos (TSX:CRON) vs. Tilray (NASDAQ:TLRY)

Cannabis investors continue to experience a steep decline in the value of their investments. However, several cannabis stocks are trading close to their 52-week lows and might gain in market value as we head into 2020. Here, we look at two stocks that have corrected significantly in the last year. The stocks are Cronos (TSX:CRON)(NASDAQ:CRON) and Tilray (NASDAQ:TLRY). Cronos went…

Read More